Rwanda Micro-module Factory
Germany-based biotechnology company BioNTech opened its first modular messenger ribonucleic acid (mRNA) vaccine manufacturing facility in Kigali, Rwanda, to promote sustainable vaccine production and end-to-end vaccine supply in African Union (AU) member states. The development, which among others aims to scale up vaccine production on the continent, was confirmed by a. Field trials in Rwanda, South Africa, and India reveal how modular cleanrooms and microfluidic lines are reshaping vaccine manufacturing at regional scale.
Read More